• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂——综述

Plasminogen activator inhibitors--a review.

作者信息

Kruithof E K

机构信息

Department of Medicine, University Hospital, Lausanne, Switzerland.

出版信息

Enzyme. 1988;40(2-3):113-21. doi: 10.1159/000469153.

DOI:10.1159/000469153
PMID:3139400
Abstract

Plasminogen activator inhibitors (PAIs) are important modulators of the activity of plasminogen activators (PAs). Several inhibitors, all belonging to the serpin family of proteins, have been implicated in PA inhibition. In order of reaction rate constants these are PAI-1, PAI-2, protease nexin and PAI-3. This review gives an overview of the physicochemical characteristics of these inhibitors as well as a comparison of their primary structure with each other and with other members of the serpin family of proteins.

摘要

纤溶酶原激活物抑制剂(PAIs)是纤溶酶原激活物(PAs)活性的重要调节剂。几种抑制剂都属于丝氨酸蛋白酶抑制剂(serpin)家族蛋白,与PA抑制有关。按照反应速率常数排序,它们依次是PAI-1、PAI-2、蛋白酶连接蛋白和PAI-3。本文综述了这些抑制剂的物理化学特性,并比较了它们彼此之间以及与丝氨酸蛋白酶抑制剂家族其他成员的一级结构。

相似文献

1
Plasminogen activator inhibitors--a review.纤溶酶原激活物抑制剂——综述
Enzyme. 1988;40(2-3):113-21. doi: 10.1159/000469153.
2
Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells.从血管平滑肌细胞中分离多种类型的纤溶酶原激活物抑制剂。
Thromb Haemost. 1989 Jun 30;61(3):517-21.
3
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.从内皮细胞中克隆人纤溶酶原激活物抑制剂的互补DNA
J Clin Invest. 1986 Dec;78(6):1673-80. doi: 10.1172/JCI112761.
4
Denaturant-induced stimulation of the beta-migrating plasminogen activator inhibitor in endothelial cells and serum.变性剂对内皮细胞和血清中β迁移纤溶酶原激活物抑制剂的诱导刺激作用。
Blood. 1986 Dec;68(6):1298-305.
5
Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.血小板纤溶酶原激活物抑制剂:与纤溶酶原激活物及活化蛋白C相互作用的纯化与特性分析
Biochemistry. 1989 Jul 11;28(14):5773-8. doi: 10.1021/bi00440a011.
6
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.人胎盘纤溶酶原激活物抑制剂的cDNA克隆及在大肠杆菌中的表达
J Biol Chem. 1987 Mar 15;262(8):3718-25.
7
Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells.视网膜色素上皮细胞产生一种潜在的纤溶酶抑制物,它在抗原性和生物化学性质上与血管内皮细胞产生的1型纤溶酶原激活物抑制物相关。
Exp Eye Res. 1989 Aug;49(2):195-203. doi: 10.1016/0014-4835(89)90090-0.
8
Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).组织型纤溶酶原激活物(t-PA)及其快速作用抑制剂(PAI-1)血液中的日间波动。
Thromb Haemost. 1988 Apr 8;59(2):329-32.
9
Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.纤溶酶原激活物抑制剂对纤溶酶原激活物的抑制动力学。“第二位点”相互作用的证据。
Biochem J. 1988 Apr 15;251(2):327-32. doi: 10.1042/bj2510327.
10
Effect of urinary trypsin inhibitor on osteoarthritis.尿胰蛋白酶抑制剂对骨关节炎的影响。
Thromb Res. 1988 Nov 1;52(3):237-45. doi: 10.1016/0049-3848(88)90083-7.

引用本文的文献

1
An updated systematic review and meta-analysis: correlation between circulating plasminogen activator inhibitor-1 levels and metabolic dysfunction-associated steatotic liver disease.一项更新的系统评价与荟萃分析:循环纤溶酶原激活物抑制剂-1水平与代谢功能障碍相关脂肪性肝病之间的相关性
BMC Gastroenterol. 2025 Aug 20;25(1):604. doi: 10.1186/s12876-025-04148-8.
2
Regulation of macrophage fibrinolysis during venous thrombus resolution.调控巨噬细胞纤溶在静脉血栓溶解中的作用。
Thromb Res. 2024 Nov;243:109149. doi: 10.1016/j.thromres.2024.109149. Epub 2024 Sep 14.
3
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.
纤溶酶原激活物抑制剂-2 与妊娠和镰状细胞贫血中的纤溶功能障碍。
Arch Gynecol Obstet. 2024 Jun;309(6):2447-2458. doi: 10.1007/s00404-023-07121-6. Epub 2023 Jul 4.
4
Effect of ethanol on lipid metabolism.乙醇对脂代谢的影响。
J Hepatol. 2019 Feb;70(2):237-248. doi: 10.1016/j.jhep.2018.10.037.
5
Plasminogen-binding proteins as an evasion mechanism of the host's innate immunity in infectious diseases.纤溶酶原结合蛋白作为感染性疾病中宿主固有免疫逃避的机制。
Biosci Rep. 2018 Oct 2;38(5). doi: 10.1042/BSR20180705. Print 2018 Oct 31.
6
Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.环状肽酶抑制剂的结构原理。
Int J Biol Sci. 2017 Sep 21;13(10):1222-1233. doi: 10.7150/ijbs.21597. eCollection 2017.
7
Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells.血液见证衰老:心血管再生细胞衰老过程中的循环分子
Front Cardiovasc Med. 2017 Oct 6;4:62. doi: 10.3389/fcvm.2017.00062. eCollection 2017.
8
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.尿激酶型纤溶酶原激活剂(uPA)对于结节性硬化症复合物2(TSC2)缺陷型肿瘤的进展至关重要。
J Biol Chem. 2017 Dec 15;292(50):20528-20543. doi: 10.1074/jbc.M117.799593. Epub 2017 Sep 27.
9
Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice.纤溶酶原激活物抑制剂-1在酒精加重的小鼠急性肺损伤中起关键作用。
Am J Respir Cell Mol Biol. 2017 Sep;57(3):315-323. doi: 10.1165/rcmb.2016-0184OC.
10
The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.血浆中残留血小板对纤溶酶原激活物抑制剂-1及纤溶酶原激活物抑制剂-1相关检测的影响。
PLoS One. 2017 Feb 3;12(2):e0171271. doi: 10.1371/journal.pone.0171271. eCollection 2017.